AMRX vs U · P/E 44, rev $2.79B vs rev $1.85B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus Unity Software Inc (U) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Unity Software Inc (U) is a software - application company listed on US.
Latest reported AMRX revenue for 2024-12-31 was $2.79B. Net income was -$73.9M. Revenue was up 16.7% from 2023-12-31 to 2024-12-31. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported U revenue for 2025-12-31 was $1.85B. Net income was -$402.8M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. U currently screens at market cap $16.98B.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. U currently screens at market cap $16.98B.
Not investment advice. Open the AMRX and U stock pages for the full models.
Not investment advice.